$56.24
-0.90-1.58%
At close: -
$56.24
0.000.00%
After Hours: Feb 21, 4:00 PM EDT
Comments
Loading...
iRadimed (NASDAQ:IRMD) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for iRadimed (IRMD)?
The most recent guidance for iRadimed (IRMD) was reported on February 13, 2025 for Q1 2025. The company provided earnings per share guidance in the range of $0.39 to $0.43, compared to the estimated EPS of $0.41. Additionally, iRadimed forecasted revenue between $0.02B and $0.02B for the quarter.
Browse guidance and forecast on all stocks.